Global Monopoly of Technology

"Mr. Lu, not only does Borch Technology have Luo Sheng's support, but Huachang Technology, another high-profile medical equipment provider, also has Luo Sheng's capital background in it."

"What did you say? Fuck this!"

The VC manager surnamed Lu heard the secretary's words, and after a while, he couldn't help but swear.

This news is both good news and bad news for other venture capital institutions. The good news is that Luo Sheng's optimism shows that his future is bright, and the bad news is that it is difficult to directly get a share of the pie.

With the limelight at the medical expo, the attention of these two newly founded technology companies has rapidly increased, especially Borch Technology, and the information of Chen Xinhe's company has been further exposed soon.

It doesn't need to be too much trouble, you can find some key information by opening the "Tianyancha" APP on your mobile phone. It didn't cause such a big movement before because there was not enough attention, and there was no big news, and there was a lack of breaking points.

One piece of information is undoubtedly attracting attention, that is, Luo Sheng's name is in it, he is an angel investor in these two technology companies, and he invested in his personal name.

Outsiders have an inexplicable sense of sudden realization. No wonder she is so beautiful. It turns out that she has Luo Sheng's support.

In today's technology world, the name "Luo Sheng" has unparalleled magic power. As long as the startups or entrepreneurs favored by this name or the institutions behind this name can quickly become the darlings of capital.

...

"I'm sorry, Huachang Technology currently has no financing plan, and has an agreement with Mr. Luo to accept only the exclusive investment of Mr. Luo, unless he voluntarily gives up financing or he agrees to a third-party venture capital institution to come in."

"Sorry Manager Lu, Borch Technology currently has no plans for external financing..."

About half an hour later, all the major VCs who heard the news went to the booth to meet Chen Xin and Chao Junhui respectively. The purpose and directness were to invest in their companies.

But they were all rejected without exception, which made people from major venture capital institutions very uncomfortable. If it is an ordinary entrepreneur and start-up company, it is shameless. There are ways and means to make it succumb to the pressure of capital. under.

But these two can't do it. With the name Luo Sheng as a cover, no one dares to do this. When it comes to the strength of capital, there is currently no venture capital institution in the world that can compete with Luo Sheng in terms of capital strength.

This kind of result makes many VC organizations feel like they want to cry without tears, and suddenly they are ecstatic when they find the baby, which seems to be within reach, but it turns out that it has nothing to do with them.

Don't worry too much.

Why do these promising start-ups have the shadow of Luo Sheng? This makes many VC institutions feel extremely uncomfortable, but also have to admire, as the legend of the first person in the contemporary technology industry is indeed well-deserved.

After politely turning down the VC people who came to talk to...  

After that, Chen Xin's assistant came over with an ieP tablet and handed it to him.

"Mr. Chen, President Luo sent you two emails."

Chen Xin took the tablet, clicked on the list of unread emails, and handed them back to his assistant in no time. Without thinking, he directly ordered: "Just do as above, and get it done as soon as possible, the sooner the better."

"Mr. Chen, but Mr. Luo didn't pay us. This batch of equipment is very expensive, and some have to be purchased in Europe."

Hearing this, Chen Xin wanted to reprimand his assistant, but held back and said, "Then use the company's working capital to do it first. Are you still worried that the boss will cheat me with this money? People who want to do things for the boss. No one thousand, no less than eight hundred, he entrusted this matter to me because he trusted and respected me, and he knew what to do?"

Don't look at Chen Xin as a careless and somewhat anti-authority young post-90s generation, but he is also a sensible master who knows things and is very sensible.

The brain is smart, and both quotients are high.

And his assistant is not Yumu's head. Hearing this, he suddenly realized, and nodded again and again: "Understood, I will deal with it myself immediately."

Chen Xin's words, his assistant also quickly heard the taste of a pun, and now this matter is left to himself, and he trusts and values ​​himself.

If you can't even realize this, then don't even think about climbing up in the future.

On the other hand, Cao Junhui also received the news, and did not neglect this matter, he arranged it immediately, and the father of the gold master had to take care of him.

Besides, this is not an ordinary errand, and there are intangible benefits in it, which shows that the relationship with Luo Sheng is different from that of other founders.

Relationship is a very wonderful thing. Everyone in the business world is a human being, and they can judge a lot of valuable information from some seemingly inadvertent little things.

In this real society, doing a thing is often done by people.

As Huachang Technology and Borch Technology became famous on the first day of the Medical Expo, they spread rapidly in the industry. In addition to the excellent products themselves, especially the blessing of the exposure of Luo Sheng's magical halo, the name The influence has been perfectly explained once again.

For a while, the two new-faced companies became the biggest winners of the medical expo. Fame, fame and fortune, the fame has gone out, will the profits be far behind?

Sure enough, what followed was that customer orders were already on their way. In the afternoon, 10 hospitals and distributors who had obtained medical device business licenses came to Bochuang Technology to place orders, and placed 50,000 orders in one go. Arm or leg prosthesis orders, this list of prosthetics 2.25 billion yuan.

But what is interesting is that Chen Xin has a special additional clause in the contract, that is, the partner can only earn a maximum of 15% of the profit, and the cooperation will be terminated if the profit exceeds the profit. Amputee offers cheap products.

 …

At present, although Borch Technology has obtained the medical device management qualification, it can also supply the market, but its production capacity has not been improved, and its own sales channel network has not been established.

This order has already packaged the company's production capacity this year. According to this trend, the market phenomenon of this product will be in short supply.

After all, it is 10 times lower in price than other prosthetic products on the market, and at the same time it has a second kill in performance. It is conceivable how fierce this competitiveness is.

Due to the lack of supply, the price will inevitably be raised by the market and the price difference will be earned by the middlemen. This obviously goes against Chen Xin's original intention of starting a business. His short-term response strategy is also simple and rude. Whoever raises the price will not give it to him. Available.

It is so capricious because so far, with the unparalleled competitiveness of Borch Technology, he is the only one who can supply the market.

However, Chen Xin also knows that it is impossible to fundamentally prevent the product from being hyped up and earn a large amount of profits in the middle, because this goes against the basic logic of economic activities that rare is precious.

There is always a way for middlemen to drive up profits.

If you really want to lower the price, the only way to solve the problem is to increase the production capacity. In addition, you have to establish your own sales channel network. Chen Xin decided to learn from the marketing model of the offline direct-sale store on the Côte d’Azur.

When the production capacity goes up and your own sales channels are established, the price will naturally drop.

Huachang Technology also gained a lot of money. On the same day, 42 major domestic and foreign pharmaceutical companies came to the door to place an order to purchase its "organ simulator" equipment, and it could even be said that they were scrambling for each other.

This set of equipment is of great benefit and significance to the research and development of biopharmaceuticals. Before this, no equipment has been able to simulate the entire circulatory metabolic process of the human body before the drug enters the clinical stage, and it can only be tested with mice.

Obviously, mice are not rigorous enough, and using volunteers will bring great risks.

However, with this set of equipment to assist the research and development of new drugs, it is different. The cost and cost of trial and error are greatly reduced, the risk of clinical trials is also greatly reduced, and the efficiency of research and development is improved at the same time, because large-scale experiments can be carried out with confidence, and the efficiency of new drug research and development is of course will increase.

This set of equipment is not cheap. The price of a single set is as high as 12.2 million US dollars, but domestic and foreign pharmaceutical companies are still scrambling to grab orders after learning about this medical device. The reason is that a slow step may delay the research and development progress of their own pharmaceutical companies. And since Huachang Technology was established not long ago, the production capacity will definitely be worse for a while, so it is even more necessary to grab orders.

Although it is not cheap, it is trivial for these large pharmaceutical companies. International pharmaceutical companies such as Roche and Novartis invest tens of billions of dollars in research and development every year.

Huachang Technology signed a total of 105 sets of purchase order contracts on the same day, with a total value of 1.28 billion US dollars, becoming the biggest winner of this medical expo, beyond everyone's expectations.

VCs who want to invest...  

Institutions are giving up now. They have already started to make massive profits, so don’t think about financing or anything.

The 42 pharmaceutical companies purchased this time are all well-known in the world. Dozens of international pharmaceutical companies such as Roche, Novartis, Pfizer, Johnson \u0026 Johnson have become customers of Huachang Technology.

It is worth mentioning that from the dozens of pharmaceutical companies that have placed orders, it can be seen that the strength of domestic pharmaceutical companies is still far behind. In the customer list of purchase orders, all the top 30 global pharmaceutical companies are listed, while domestic pharmaceutical companies None of the companies are on this list.

There is no doubt that the level of biopharmaceuticals is one of the important indicators to measure a country's comprehensive national strength, and it is an important field involving the national economy and people's livelihood, especially the outbreak of public health emergencies, which is of irreplaceable importance.

According to the latest ranking of global pharmaceutical companies released by the North American "Pharmaceutical Manager" magazine this year, 5 of the top 10 pharmaceutical companies are in North America, 2 in Switzerland, 1 in France, and 1 in Japan.

There are only four top-ranked pharmaceutical manufacturers in China that are also ranked 48th and 1st in the global pharmaceutical company rankings.

In the field of medical technology, there is obviously still a long way to go, and this time Huachang Technology has made great achievements, attracting the top 30 pharmaceutical companies in the world, and they are scrambling to place orders for their medical equipment. It can be said that both I have made a lot of money for myself, and I have also earned face for this medical expo, which undoubtedly greatly stimulated the development of the domestic medical industry.

Although the domestic pharmaceutical companies are not as good as the top 30 in the world, Huachang Technology gives priority to supplying several domestic pharmaceutical companies, and the number of equipment is four sets. On the contrary, the international pharmaceutical companies that are not bad money are not only lined up behind, Moreover, a company currently only supplies two sets, and it is impossible to increase the price and increase the quantity.

International pharmaceutical companies are very dissatisfied with this, but they can only bear it. Who makes Huachang Technology the only equipment provider in the world that can produce a complete set of human metabolic cycle simulation?

What is the significance of this product for the development of clinical medicine, pharmaceutical companies engaged in the field of biopharmaceuticals know best.

...